Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-12

Clinical Trial Update: Treatment of Periorbicular Hyperchromia Comparing 10% Thioglycolic Acid Peeling Versus Pulsed Intense Light [Phase 4]

View source ↗

Summary

Phase 4 trial comparing 10% thioglycolic acid peeling to pulsed intense light for periorbital hyperchromia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 10% thioglycolic acid peeling (thioglycolic acid peeling)
  • Pulsed Intense Light (pulsed intense light)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Periorbital Disorder | Phase 4 | Status: UNKNOWN